Planet Labs (PL) director sells 36,500 shares under 10b5-1 plan

Filing Impact

(High)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

Planet Labs PBC director Brennan Ita M sold 36,500 shares of Class A Common Stock in an open‑market transaction. The sale occurred on April 15, 2026 at a weighted average price of $33.9063 per share, under a Rule 10b5-1 trading plan adopted on January 14, 2026.

Following this sale, the director holds 264,158 shares directly. This includes 3,478 RSUs that vest in equal quarterly installments on the 15th of June and 32,468 RSUs that fully vest on the earlier of the first anniversary of the grant or the issuer's next annual stockholder meeting.

Insider Trade Summary 10b5-1

Net Seller: 36,500 shares ($1,237,580)

Net Sell 1 txn

Insider Brennan Ita M

Role Director

Sold 36,500 shs ($1.24M)

Type	Security	Shares	Price	Value
Sale	Class A Common Stock	36,500	$33.9063	$1.24M

Holdings After Transaction: Class A Common Stock — 264,158 shares (Direct)

Footnotes (1)

This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 14, 2026. The sales were executed in multiple trades at prices ranging from $32.86 to $35.14. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. Includes (a) 3,478 RSUs that vest in equal quarterly installments on the 15th of June; and (b) 32,468 RSUs which fully vest on the earlier of (i) the first anniversary of the grant or (ii) the date of the issuer's next annual meeting of stockholders to occur following the grant. The RSUs represent a contingent right to receive one share of issuer's Class A Common Stock each and have no expiration date.

Key Figures

Shares sold: 36,500 shares Weighted average sale price: $33.9063 per share Shareholding after transaction: 264,158 shares +3 more

6 metrics

Shares sold 36,500 shares Open-market sale of Class A Common Stock on April 15, 2026

Weighted average sale price $33.9063 per share Average price for 36,500 shares sold in multiple trades

Shareholding after transaction 264,158 shares Total direct Class A Common Stock holdings following the sale

RSUs vesting quarterly 3,478 RSUs Vest in equal quarterly installments on the 15th of June

RSUs with time/meeting vesting 32,468 RSUs Vesting on first grant anniversary or next annual stockholder meeting

Sale price range $32.86–$35.14 per share Range of individual trade prices for the reported sale

Key Terms

Rule 10b5-1 trading plan, RSUs, weighted average sale price, Class A Common Stock

4 terms

Rule 10b5-1 trading plan regulatory

"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

RSUs financial

"Includes (a) 3,478 RSUs that vest in equal quarterly installments on the 15th of June"

RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.

weighted average sale price financial

"The price reported reflects the weighted average sale price"

Class A Common Stock financial

"The RSUs represent a contingent right to receive one share of issuer's Class A Common Stock each"

Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

Form 4 Insider Transactions: What Each Field Means →

04/17/2026 - 04:00 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Brennan Ita M

(Last)

(First)

(Middle)

C/O PLANET LABS PBC

645 HARRISON STREET, FLOOR 4

(Street)

SAN FRANCISCO

CALIFORNIA

94107

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Planet Labs PBC [ PL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Class A Common Stock	04/15/2026		S		36,500⁽¹⁾	D	$33.9063⁽²⁾	264,158⁽³⁾	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 14, 2026.

2. The sales were executed in multiple trades at prices ranging from $32.86 to $35.14. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

3. Includes (a) 3,478 RSUs that vest in equal quarterly installments on the 15th of June; and (b) 32,468 RSUs which fully vest on the earlier of (i) the first anniversary of the grant or (ii) the date of the issuer's next annual meeting of stockholders to occur following the grant. The RSUs represent a contingent right to receive one share of issuer's Class A Common Stock each and have no expiration date.

	By: /s/ LeeAnn Linck, Attorney-in-fact for: Ita M Brennan	04/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Planet Labs (PL) report in this Form 4?

Planet Labs reported that director Brennan Ita M sold 36,500 shares of Class A Common Stock. The open-market sale took place on April 15, 2026 at a weighted average price of $33.9063 per share, as part of a disclosed trading plan.

At what prices were Brennan Ita M’s Planet Labs (PL) shares sold?

The shares were sold in multiple trades at prices ranging from $32.86 to $35.14. The Form 4 reports a weighted average sale price of $33.9063 per share for the 36,500 Class A Common Stock shares sold on April 15, 2026.

How many Planet Labs (PL) shares does Brennan Ita M hold after the sale?

After the sale, Brennan Ita M holds 264,158 shares of Planet Labs Class A Common Stock directly. This total includes restricted stock units (RSUs) that will convert into shares as they vest according to the described schedules in the filing.

Was the Planet Labs (PL) insider sale made under a Rule 10b5-1 plan?

Yes. The filing states the transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 14, 2026. Such plans pre-schedule trades, making the timing less indicative of changing sentiment.

What restricted stock units (RSUs) are reported for Planet Labs (PL) director Brennan Ita M?

The holding includes 3,478 RSUs that vest in equal quarterly installments on the 15th of June and 32,468 RSUs that fully vest on the earlier of the first anniversary of the grant or Planet Labs’ next annual stockholder meeting.

What type of security did Planet Labs (PL) director sell in this transaction?

The transaction involved Planet Labs’ Class A Common Stock. The Form 4 shows a non-derivative open-market sale of 36,500 shares, with the director retaining a substantial remaining direct position and additional RSUs scheduled to vest over time.